|
|
|
| Preparation and Identification of Chicken-derived Single-chain Variable Fragments Against the VP1-CDE Protein of Feline calicivirus |
| WANG Hong-Mei1, LIU Yi-Han1, LIU Chao2, ZHAO Zhen-Ping1, JIN Ya-Li1, ZHU Xin-Long1, WEI Yan-Quan1,* |
1 College of Veterinary Medicine, Gansu Agricultural University, Lanzhou 730070, China;
2 Chongqing Hesheng Biotechnology Company Limited, Chongqing 402460, China |
|
|
|
|
Abstract Accurate diagnosis of Feline calicivirus (FCV) infection relies on specific antibody tools, and single-chain variable fragments (scFvs) show important application potential in clinical practice. In this study, the FCV VP1-CDE protein expressed and purified through prokaryotic expression was used as the immunogen to immunize chickens (Gallus gallus domesticus). A phage-displayed scFv library was constructed and positive clones were obtained by solid-phase panning. Eukaryotic expression vectors were constructed and expressed in human embryonic kidney 293F cells, followed by purification. The binding activities were verified by Western blot, indirect immunofluorescence assay (IFA), and bio-layer interferometry (BLI). The results showed that soluble VP1-CDE protein was successful obtained. The titer of chicken serum was higher than 1∶64 000 after 5 immunizations. A phage-display library with a capacity of 5.25×107 CFU/mL and good diversity was constructed. Thirty-five recombinant phage cloned with strong reactivity were obtained after panning, and 5 unique scFv sequences were acquired. Western blot analysis demonstrated that 5 clones (X1A2, X2B2, X2C1, X2E1 and X2G5) could specifically bind to the VP1-CDE protein. IFA results indicated that 3 of them (X2B2, X2E1 and X2G5) exhibited good binding activity to intact viral particles, which was further confirmed by BLI. In conclusion, this study successfully constructed a phage-displayed chicken scFv library against FCV VP1-CDE protein and obtained 3 scFv clones with high binding activity, providing valuable materials for basic research and diagnostic development of FCV.
|
|
Received: 26 January 2026
|
|
|
| Fund:甘肃省技术创新引导计划-东西协作专题项目(23CXNA0016); 兰州市青年科技人才创新项目(2024-QN-165); 甘肃农业大学人才引进科研启动资金项目(GAU-KYQD-2018-16); 甘肃省高校研究生“创新之星”项目(2025CXZX-773) |
|
Corresponding Authors:
*sdwyq2007@163.com
|
|
|
|
[1] 程晨曦. 2018. 猫杯状病毒单克隆抗体的制备及其抗原表位鉴定[D]. 硕士学位论文, 中国农业科学院, 导师: 曲连东, pp. 2-3.
(Cheng C X.2018. Preparation of monoclonal antibodies against Feline calicivirus and epitope mapping[D]. Thesis for M.S., Chinese Academy of Agricultural Sciences, Supervisor: Qu L D, pp. 2-3.)
[2] 范佳铭, 龙丽瑾, 刘文韬, 等. 2024. 大容量天然鸡源噬菌体单链抗体库的构建[J]. 疾病监测, 39(04): 466-471.
(Fan J M, Long L J, Liu W T, et al.2024. Construction of a large naïve chicken-derived phage antibody library[J]. Disease Surveillance, 39(04): 466-471.)
[3] 焦子琛, 王子豪, 匡宇竹, 等. 2024. 单链抗体的新研究进展及其在医学中的应用[J]. 现代免疫学, 44(06): 530-535.
(Jiao Z C, Wang Z H, Kuang Y Z, et al.2024. Research progress of single-chain antibody fragments and their medical application[J]. Current Immunology, 44(06): 530-535.)
[4] 孔梓安, 宋想胜, 程如楠, 等. 2022. 牛病毒性腹泻-黏膜病病毒噬菌体单链抗体库的构建和筛选[J]. 中国农业大学学报, 27(09): 64-71.
(Kong Z A, Song X S, Cheng R N, et al.2022. Construction and screening of ScFv against Bovine viral diarrhea virus[J]. Journal of China Agricultural University, 27(09): 64-71.)
[5] 肖丽荣, 李彬, 王家伟, 等. 2022. 牛冠状病毒N蛋白抗体库构建与单链抗体筛选[J]. 中国兽医杂志, 58(10): 29-34.
(Construction of phage display antibody library and screening of single chain antibody against Bovine coronavirus N protein[J]. Chinese Journal of Veternary Medicine, 58(10): 29-34)
[6] 尹慧敏, 吕海, 迟莹, 等. 2025. 人源性抗SARS-CoV-2单链抗体文库的构建及广谱中和抗体的筛选与鉴定[J]. 细胞与分子免疫学杂志, 41(02): 154-160.
(Yin H M, LYU H, Chi Yet al.2025. Construction of a human anti-SARA-CoV-2scFv library and identification of broad-spectrum neutralizing antibodies[J]. Chinese Journal of Cellular Molecular Immunology, 41(02): 154-160.)
[7] 张红, 刘钧珂, 张改平, 等. 2007. 鸡免疫球蛋白基因结构与抗体多样性产生的分子机制[J]. 河南农业科学, (02): 102-105.
(Zhang H, Liu J K, Zhang K P, et al.2007. Gene structure of chicken immunoglobulins and molecular mechanisms underlying antibody giversity generation[J]. Journal of Hebei Agricultural Sciences, 2007, (02): 102-105.)
[8] 张心怡. 2025. 人4型腺病毒抗体筛选与中和机制研究[D]. 硕士学位, 南京中医药大学, 导师: 李建民, pp. 51-53.
(Zhang X Y.2025. Screening and neutralization mechanism of human adenovirus type 4 antibody[D]. Thesis for M.S., Nanjing University of Chinese Medicine, Supervisor: Li J M, pp. 51-53.)
[9] 张泽宇, 董宁宁, 谈晓梅, 等. 2024. 猫杯状病毒VP1蛋白的单克隆抗体制备及抗原表位鉴定[J]. 畜牧兽医学报, 55(12): 5784-5791.
(Zhang Z Y, Dong N N, Tan X M, et al.2024. Preparation of monoclonal antibodies against Feline calicivirus VP1 protein and identification of antigenic epitope[J]. Acta Veterinaria et Zootechnica Sinica, 55(12): 5784-5791.)
[10] 朱新龙, 王红梅, 刘怡涵, 等. 2026. 猫杯状病毒VP1及其截短体VP1-CDE重组蛋白的表达纯化与免疫效果评价[J/OL]. 中国兽医科学, 3: 319-325.
(Zhu X L, Wang H M, Liu Y H, et al.2026. Expression, purification, and immunogenicity evaluation of recombinant Feline calicivirus VP1 and its truncated variant VP1-CDE[J/OL]. Chinese Veterinary Science, 3: 319-325.)
[1] Bhella D, Gatherer D, Chaudhry Y, et al.2008. Structural insights into calicivirus attachment and uncoating[J]. Journal of Virology, 82(16): 8051-8058.
[2] Brunet S, Sigoillot-Claude C, Pialot D, et al.2019. Multiple correspondence analysis on amino acid properties within the variable region of the capsid protein shows differences between classical and virulent systemic Feline calicivirus strains[J]. Viruses-Basel, 11(12).
[3] Cheng J, Tang A, Chen J, et al.2023. A cDNA-based reverse genetics system for Feline calicivirus identifies the 3' untranslated region as an essential element for viral replication[J]. Archives of Virology, 168(2): 33.
[4] Gong Y, Chen X, Fan J, et al.2024. Construction and validation of chicken immune scFv antibody library against Helicobacter pylori[J]. Microorganisms, 12(6).
[5] Heng W, Zang D, Li R, et al.2025. A novel replication-deficient FCV vaccine provides strong immune protection in cats[J]. Journal of Virology, 99(8): e0009325.
[6] Horimoto T, Takeda Y, Iwatsuki-Horimoto K, et al.2001. Capsid protein gene variation among feline calicivirus isolates[J]. Virus Genes, 23(2): 171-174.
[7] Kim S, Cheng Y, Fang Z, et al.2024. Molecular epidemiology and phylogenetic analysis of feline calicivirus in Kunshan, China[J]. Virology Journal, 21(1): 50.
[8] Lee C, Wu C, Chiang J, et al.2025. Chicken-derived single-chain variable fragments targeting monkeypox virus A29L protein[J]. Biotechnology Journal, 20(2): e202400634.
[9] Liu C, Liu Y, Qian P, et al.2020. Molecular and serological investigation of cat viral infectious diseases in China from 2016 to 2019[J]. Transboundary and Emerging Diseases, 67(6): 2329-2335.
[10] Li L, Liu Z, Shi J, et al.2024. The CDE region of Feline calicivirus VP1 protein is a potential candidate subunit vaccine[J]. BMC Veterinary Research, 20(1): 80.
[11] Oka T, Takagi H, Tohya Y.2014. Development of a novel single step reverse genetics system for Feline calicivirus[J]. Journal of Virological Methods, 207: 178-181.
[12] Rasri N, Tabtimmai L, Kraiya C, et al.2023. Generation of a single-chain variable fragment antibody against feline immunoglobulin G for biosensor applications[J]. ACS Omega, 8(30): 27688-27696.
[13] Sosnovtsev S V, Sosnovtseva S A, Green K Y.1998. Cleavage of the Feline calicivirus capsid precursor is mediated by a virus-encoded proteinase[J]. Journal of Virology, 72(4): 3051-3059.
[14] Sun F, Guo X, Guo J, et al.2023. Genetic evolution and biological characteristics of Feline caliciviruses isolated from dogs[J]. Transboundary and Emerging Diseases, 2023: 1145176.
[15] Sun Y, Li T, Liu J, et al.2026. A recombinant Fc-fused nanobody provides complete protection against Feline parvovirus infection[J]. Veterinary Microbiology, 312: 110837.
[16] Yamanaka H I, Inoue T, Ikeda-Tanaka O.1996. Chicken monoclonal antibody isolated by a phage display system[J]. Journal of Immunology, 157(3): 1156-1162.
[17] Yang H, Chae J, Kim H, et al.2025. Generation of chicken antibody libraries and selection of antigen binders[J]. Cold Spring Harb Protocols, 2025(8): pdb.top108210.
[18] Zolla-Pazner S.1996. Mechanisms contributing to the neutralization of HIV-1[J]. Immunology Letters, 51(1-2): 89-93. |
|
|
|
